Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study.
about
Overview of the Diagnostic Methods Used in the Field for Human African Trypanosomiasis: What Could Change in the Next Years?A current analysis of chemotherapy strategies for the treatment of human African trypanosomiasisAntiparasitic therapySpermine synthase deficiency leads to deafness and a profound sensitivity to alpha-difluoromethylornithine.Human African trypanosomiasis in South Sudan: how can we prevent a new epidemic?Midgut expression of immune-related genes in Glossina palpalis gambiensis challenged with Trypanosoma brucei gambiense.In-hospital safety in field conditions of nifurtimox eflornithine combination therapy (NECT) for T. b. gambiense sleeping sickness.Whole-organism high-throughput screening against Trypanosoma brucei brucei.A mixed methods study of a health worker training intervention to increase syndromic referral for gambiense human African trypanosomiasis in South Sudan.A method to improve the efficacy of topical eflornithine hydrochloride cream.From health advice to taboo: community perspectives on the treatment of sleeping sickness in the Democratic Republic of Congo, a qualitative study.Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sicknessTreatment options for second-stage gambiense human African trypanosomiasis.The Trypanosoma brucei gambiense secretome impairs lipopolysaccharide-induced maturation, cytokine production, and allostimulatory capacity of dendritic cellsPharmacokinetics and pharmacodynamics utilizing unbound target tissue exposure as part of a disposition-based rationale for lead optimization of benzoxaboroles in the treatment of Stage 2 Human African Trypanosomiasis.Controlling sleeping sickness - a review.Trypanosomiasis, cardiomyopathy and the risk of ischemic stroke.Chemotherapy against human African trypanosomiasis: is there a road to success?Neglected disease - african sleeping sickness: recent synthetic and modeling advances.Human African trypanosomiasis in endemic populations and travellers.Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis.Secreted proteases of Trypanosoma brucei gambiense: possible targets for sleeping sickness control?Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine Médecins Sans Frontières programmes.Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need.Nifurtimox-eflornithine combination therapy for second-stage gambiense human African trypanosomiasis: Médecins Sans Frontières experience in the Democratic Republic of the Congo.The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain.African sleeping sickness.Genetically Validated Drug Targets in Leishmania; Current Knowledge and Future Prospects.Alpha-Difluoromethylornithine, an Irreversible Inhibitor of Polyamine Biosynthesis, as a Therapeutic Strategy against Hyperproliferative and Infectious Diseases.Chemotherapy of human african trypanosomiasis.Mortality trends and risk factors in advanced stage-2 Human African Trypanosomiasis: A critical appraisal of 23 years of experience in the Democratic Republic of Congo.Monitoring the use of nifurtimox-eflornithine combination therapy (NECT) in the treatment of second stage gambiense human African trypanosomiasis
P2860
Q26778571-4EFB68EC-60CF-4BF1-BE63-51335C03E618Q26820381-0E8F8809-1F13-421B-A5CF-3189A2B62604Q28239164-91FFBD06-089C-4FE0-A7FE-C18A103CD626Q30484125-CC2862D1-7B7B-4239-A78C-9828D300864CQ34293008-B96CABF7-7045-409E-9FA6-2EC5B0A9D411Q34481108-68126856-C6E2-4539-964D-B72ECE87C112Q34500886-C0016CAB-5F17-4D90-A6A8-868E830B0932Q34642037-E6332FAF-D9FF-4675-916D-BED7F8758F53Q35126629-23DBA51F-4D15-44A0-851B-189DD857C5DCQ35143346-A35432F5-F395-44D7-83DF-0E89A7A42190Q35345427-B3E6E57A-FB9B-4E15-92AB-17E717963B78Q35598430-486E9A69-B4B5-4B16-82CB-C10DBD8D0F2AQ36551049-D499F2F0-0506-4921-AE1F-C74BB94B0EB9Q37123713-F45D9082-8CBC-474A-B444-87C2C5F049CCQ37449679-229CAC6E-F647-4DC9-BC2C-3429B06AE82AQ37582546-42B22158-17E8-40F0-A7DC-E8A994AE2F4BQ37744965-82C77451-6BE7-4162-A17A-FA7B8C0CD85EQ37801690-601E7C05-A308-475A-A69C-F2FAE71F3D32Q37925570-F70418A9-ECD5-4EF7-90B5-D122CD6B0928Q37929054-4016833B-6C34-4A0C-9EDA-0286400F254DQ37981773-1E2FD99F-60CF-4401-A054-E90742807772Q38095854-20126C9B-F422-497A-BB86-FFAB174ADEF3Q38875419-876BA9CE-F7CE-47A9-8FC2-9E467870207BQ39003990-89B0ECC5-FFFA-484F-8EFF-DC62215EE4BAQ39223286-6A9EB89F-21D9-48BF-9DFB-B6A065CFDFD1Q41502922-AFC75E79-0420-45C6-8A2A-A622134BB0E8Q43089194-B44D8DF4-F6E0-40FD-8667-DD106E466A44Q47702679-631E7CF3-05E0-4049-9BEF-AD6A24049826Q48506495-D505AAE7-9C84-49C1-936B-F69BF609638BQ52595328-8AA8926E-BFC6-4794-BC39-F4CF14C760C7Q55322154-7FEB4621-7BC0-4D48-8221-48A22CCB28D3Q56504613-9DBE3737-F0C0-4595-8D0F-34D20B0EA6F6
P2860
Safety and effectiveness of first line eflornithine for Trypanosoma brucei gambiense sleeping sickness in Sudan: cohort study.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Safety and effectiveness of fi ...... ckness in Sudan: cohort study.
@ast
Safety and effectiveness of fi ...... ckness in Sudan: cohort study.
@en
Safety and effectiveness of fi ...... ckness in Sudan: cohort study.
@nl
type
label
Safety and effectiveness of fi ...... ckness in Sudan: cohort study.
@ast
Safety and effectiveness of fi ...... ckness in Sudan: cohort study.
@en
Safety and effectiveness of fi ...... ckness in Sudan: cohort study.
@nl
prefLabel
Safety and effectiveness of fi ...... ckness in Sudan: cohort study.
@ast
Safety and effectiveness of fi ...... ckness in Sudan: cohort study.
@en
Safety and effectiveness of fi ...... ckness in Sudan: cohort study.
@nl
P2093
P2860
P921
P1433
P1476
Safety and effectiveness of fi ...... ckness in Sudan: cohort study.
@en
P2093
Barbara Burke
Cathy Hewison
Gerardo Priotto
Guillaume Grillet
Isaac Badi Fursa
Loretxu Pinoges
Manica Balasegaram
Nathalie Nicolay
P2860
P304
P356
10.1136/BMJ.39485.592674.BE
P407
P577
2008-03-05T00:00:00Z